These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 29893624)
1. Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures. Hall ES; McAllister JM; Wexelblatt SL Popul Health Manag; 2019 Feb; 22(1):19-24. PubMed ID: 29893624 [TBL] [Abstract][Full Text] [Related]
2. Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records. Hall ES; Wexelblatt SL; Greenberg JM Popul Health Manag; 2018 Dec; 21(6):486-492. PubMed ID: 29485940 [TBL] [Abstract][Full Text] [Related]
3. Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization. Percy Z; Brokamp C; McAllister JM; Ryan P; Wexelblatt SL; Hall ES J Pediatr; 2020 Jul; 222():52-58.e1. PubMed ID: 32423682 [TBL] [Abstract][Full Text] [Related]
4. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure. Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326 [TBL] [Abstract][Full Text] [Related]
5. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population. Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378 [TBL] [Abstract][Full Text] [Related]
6. Maternal opioid exposure, neonatal abstinence syndrome, and infant healthcare utilization: A retrospective cohort analysis. Ko JY; Yoon J; Tong VT; Haight SC; Patel R; Rockhill KM; Luck J; Shapiro-Mendoza C Drug Alcohol Depend; 2021 Jun; 223():108704. PubMed ID: 33894458 [TBL] [Abstract][Full Text] [Related]
8. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
9. The relationship between gestational age and the severity of neonatal abstinence syndrome. Gibson KS; Stark S; Kumar D; Bailit JL Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650 [TBL] [Abstract][Full Text] [Related]
10. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019. Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614 [TBL] [Abstract][Full Text] [Related]
11. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine. O'Connor AB; Kelly BK; O'Brien LM Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206 [TBL] [Abstract][Full Text] [Related]
12. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. King RS; Peacock-Chambers E; Wilson D; Shimer J; Foss S; Visintainer P; Singh R J Neonatal Perinatal Med; 2021; 14(4):463-473. PubMed ID: 33843701 [TBL] [Abstract][Full Text] [Related]
13. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014. Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557 [TBL] [Abstract][Full Text] [Related]
14. Identification of Prenatal Opioid Exposure Within Health Administrative Databases. Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33376211 [TBL] [Abstract][Full Text] [Related]
15. The Association Between Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital Births. Short VL; Gannon M; Abatemarco DJ Breastfeed Med; 2016 Sep; 11():343-9. PubMed ID: 27529500 [TBL] [Abstract][Full Text] [Related]
16. Early Intervention Referral and Enrollment Among Infants with Neonatal Abstinence Syndrome. Peacock-Chambers E; Leyenaar JK; Foss S; Feinberg E; Wilson D; Friedmann PD; Visintainer P; Singh R J Dev Behav Pediatr; 2019; 40(6):441-450. PubMed ID: 31107767 [TBL] [Abstract][Full Text] [Related]
17. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related]
18. Hepatitis C Screening in Mothers and Infants Exposed to Opioids. Bell R; Wolfe I; Cox D; Thakarar K; Lucas L; Craig A Hosp Pediatr; 2019 Aug; 9(8):639-642. PubMed ID: 31292149 [TBL] [Abstract][Full Text] [Related]
19. Use of naltrexone in treating opioid use disorder in pregnancy. Towers CV; Katz E; Weitz B; Visconti K Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396 [TBL] [Abstract][Full Text] [Related]
20. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]